{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:04:58Z","timestamp":1790424298779,"version":"4.1.0"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:00:00Z","timestamp":1585180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:00:00Z","timestamp":1585180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Thrombotic thrombocytopenic purpura (TTP) is a life-threatening thrombotic microangiopathy caused by severely reduced activity of the von-Willebrand factor-cleaving protease ADAMTS13, mainly caused by anti-ADAMTS-13 antibodies. Although several test systems for ADAMTS13 measurement exist, long turn-around times hamper the usability in daily practice. We performed a method comparison study for two commercially available ADAMTS13 assays and evaluated the agreement between the fully-automated rapid turn-over HemosIL AcuStar ADAMTS13 Activity assay and the manually performed TECHNOZYM ADAMTS-13 Activity assay. Twenty-four paired test samples derived from 10 consecutively recruited patients (n\u2009=\u20098, acquired TTP; n\u2009=\u20091, atypical hemolytic uremic syndrome; n\u2009=\u20091, control), of which nine test samples were collected in case of clinically apparent TTP and 13 samples were collected from TTP patients in clinical remission were included. Overall correlation between the TECHNOZYM and AcuStar assay was good with a Pearson R of 0.93 (p\u2009&lt;\u20090.001). Agreement between the assays assessed with the Passing\u2013Bablok analysis showed high agreement with an Intercept of \u2009\u2212\u20092.56 (95% confidence interval [CI],\u2009\u2212\u20095.07 to \u2009\u2212\u20090.86) and Slope of 1.04 (95% CI 0.84\u20131.17). The absolute mean bias was 2.54% (standard difference [SD], 6.38%; 95% CI\u2009to\u200910.0\u201315.05%). Intra-method reliability was high with an absolute mean bias of\u2009\u2212\u20090.13% (SD 3.21%; 95% CI\u2009to\u20096.42\u20136.16%). The observer agreement for categorial thresholds (&gt;\u2009or\u2009&lt;\u200910% ADAMTS3 activity) was kappa\u2009=\u20090.82 (95% CI 0.59\u20131.0). Conclusively, overall agreement between the testing methods was sufficient and we support previously published data suggesting the AcuStar assay being a valuable and accurate tool for ADAMTS13 activity testing and TTP diagnostics.<\/jats:p>","DOI":"10.1007\/s11239-020-02086-8","type":"journal-article","created":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T12:03:05Z","timestamp":1585224185000},"page":"628-631","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Evaluation of a rapid turn-over, fully-automated ADAMTS13 activity assay: a method comparison study"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7726-6622","authenticated-orcid":false,"given":"Jan","family":"Stratmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine-Nana","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Miesbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,26]]},"reference":[{"issue":"3","key":"2086_CR1","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","volume":"158","author":"M Scully","year":"2012","unstructured":"Scully M, Hunt BJ, Benjamin S, Liesner R, Rose P, Peyvandi F et al (2012) Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol 158(3):323\u2013335. https:\/\/doi.org\/10.1111\/j.1365-2141.2012.09167.x","journal-title":"Br J Haematol"},{"issue":"4","key":"2086_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1538-7836.2010.03761.x","volume":"8","author":"F Peyvandi","year":"2010","unstructured":"Peyvandi F, Palla R, Lotta LA, Mackie I, Scully MA, Machin SJ (2010) ADAMTS-13 assays in thrombotic thrombocytopenic purpura. J Thromb Haemost 8(4):631\u2013640. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.03761.x","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2086_CR3","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1111\/trf.14546","volume":"58","author":"CP Nixon","year":"2018","unstructured":"Nixon CP, Cheves TA, Sweeney JD (2018) Availability of an ADAMTS13 assay with rapid turnaround time may avoid interhospital transfer in patients with thrombotic microangiopathy. Transfusion 58(5):1328\u20131329. https:\/\/doi.org\/10.1111\/trf.14546","journal-title":"Transfusion"},{"issue":"2","key":"2086_CR4","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/trf.13359","volume":"56","author":"NT Connell","year":"2016","unstructured":"Connell NT, Cheves T, Sweeney JD (2016) Effect of ADAMTS13 activity turnaround time on plasma utilization for suspected thrombotic thrombocytopenic purpura. Transfusion 56(2):354\u2013359. https:\/\/doi.org\/10.1111\/trf.13359","journal-title":"Transfusion"},{"issue":"11","key":"2086_CR5","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1055\/s-0039-1696718","volume":"119","author":"C Valsecchi","year":"2019","unstructured":"Valsecchi C, Mirabet M, Mancini I, Biganzoli M, Schiavone L, Faraudo S et al (2019) Evaluation of a new, rapid, fully automated assay for the measurement of ADAMTS13 activity. Thromb Haemost 119(11):1767\u20131772. https:\/\/doi.org\/10.1055\/s-0039-1696718","journal-title":"Thromb Haemost"},{"issue":"5","key":"2086_CR6","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1055\/s-0038-1641151","volume":"118","author":"J Favresse","year":"2018","unstructured":"Favresse J, Lardinois B, Chatelain B, Jacqmin H, Mullier F (2018) Evaluation of the fully automated hemosil acustar ADAMTS13 activity assay. Thromb Haemost 118(5):942\u2013944. https:\/\/doi.org\/10.1055\/s-0038-1641151","journal-title":"Thromb Haemost"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02086-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-020-02086-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02086-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T01:01:30Z","timestamp":1616720490000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-020-02086-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,26]]},"references-count":6,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["2086"],"URL":"https:\/\/doi.org\/10.1007\/s11239-020-02086-8","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,26]]},"assertion":[{"value":"26 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}